dichloromethyl 2-methoxyethyl ether | 104392-41-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: dichloromethyl 2-methoxyethyl ether
• 英文别名: 1-(dichloromethoxy)-2-methoxyethane
• CAS: 104392-41-8
• 化学式: C₄H₈Cl₂O₂
• 分子量: 159.012
• InChiKey: IMSWEHIZVIKMQK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  8
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  dichloromethyl 2-methoxyethyl ether 、 二乙基亚磷酸氢酯 以 四氢呋喃 为溶剂， 生成 tetraethyl (2-methoxyethoxymethylene)-bisphosphonate
  参考文献：
  名称：

  Bisphosphonic acids and esters

  摘要：

  本发明涉及迄今为止未知的化合物，其化学式为I，在该式中，R.sub.1是直链或支链、饱和或不饱和的脂肪族或脂环族C.sub.1-C.sub.10烃基，芳基或芳基-C.sub.1-C.sub.4-烷基基团，R.sub.1如有必要，可以是未取代的或取代的，取代基为直链或支链C.sub.1-C.sub.4-烷基，氨基，C.sub.1-C.sub.4-烷氨基，二-(C.sub.1-C.sub.4-烷基)-氨基，羧基，C.sub.1-C.sub.4-烷氧羰基，羟基，C.sub.1-C.sub.4-烷氧基，苯氧基，巯基，C.sub.1-C.sub.4-烷硫基，苯硫基，卤素，三氟甲基；R.sub.2代表氢、C.sub.1-C.sub.8-烷基，芳基-C.sub.1-C.sub.4-烷基或卤素；X为氧或硫，n为0到2的整数；但R.sub.2不能为氢或甲基，如果n=0且R.sub.1为甲基。本发明的化合物在人类和兽医实践中具有重要价值。

  公开号：

  US04732998A1
• 作为产物：
  描述：

  甲酸2-甲氧基乙酯 在 甲酸 、 五氯化磷 作用下， 以 乙二醇甲醚 为溶剂， 生成 dichloromethyl 2-methoxyethyl ether
  参考文献：
  名称：

  Bisphosphonic acids and esters

  摘要：

  本发明涉及迄今为止未知的化合物，其化学式为I，在该式中，R.sub.1是直链或支链、饱和或不饱和的脂肪族或脂环族C.sub.1-C.sub.10烃基，芳基或芳基-C.sub.1-C.sub.4-烷基基团，R.sub.1如有必要，可以是未取代的或取代的，取代基为直链或支链C.sub.1-C.sub.4-烷基，氨基，C.sub.1-C.sub.4-烷氨基，二-(C.sub.1-C.sub.4-烷基)-氨基，羧基，C.sub.1-C.sub.4-烷氧羰基，羟基，C.sub.1-C.sub.4-烷氧基，苯氧基，巯基，C.sub.1-C.sub.4-烷硫基，苯硫基，卤素，三氟甲基；R.sub.2代表氢、C.sub.1-C.sub.8-烷基，芳基-C.sub.1-C.sub.4-烷基或卤素；X为氧或硫，n为0到2的整数；但R.sub.2不能为氢或甲基，如果n=0且R.sub.1为甲基。本发明的化合物在人类和兽医实践中具有重要价值。

  公开号：

  US04732998A1

文献信息

• DERIVATIVES OF METHYLENE-BISPHOSPHONIC ACID, PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION
  申请人：LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB)

  公开号：EP0191044A1

  公开（公告）日：1986-08-20
• US4732998A
  申请人：——

  公开号：US4732998A

  公开（公告）日：1988-03-22
• [EN] DERIVATIVES OF METHYLENE-BISPHOSPHONIC ACID, PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION
  申请人：LEO PHARMACEUTICAL PRODUCTS LTD. A/S

  公开号：WO1986000902A1

  公开（公告）日：1986-02-13

  (EN) Hitherto unknown compounds of formula (I) in which R1 is a straight or branched, saturated or unsaturated aliphatic or alicyclic C1-C10 hydrocarbon radical, an aryl or an aryl-C1-C4-alkyl radical, R1 if desired being unsubstituted or substituted with straight or branched C1-C4-alkyl, amino, C1-C4-alkylamino, di-(C1-C4-alkyl)-amino, carboxy, C1-C4-alkoxycarbonyl, hydroxy, C1-C4-alkoxy, phenoxy, mercapto, C1-C4-alkylthio, phenylthio, halogen, trifluoromethyl; R2 stands for hydrogen, C1-C8-alkyl, aryl-C1-C4-alkyl or halogen; X is O or S and n is an integer from 0 to 2; with the proviso that R2 cannot be hydrogen or methyl if n=0 and R1 is methyl. The compounds of the invention are valuable in the human and veterinary practice.(FR) Dans des composés jusqu'ici inconnus ayant la formule (I), R1 est un radical hydrocarbure C1-C¿10 alicyclique ou aliphatique saturé ou non saturé, droit ou ramifié, un radical aryle ou aryle - C1C4-alcoyle, R1 pouvant être, si voulu, non substitué ou substitué par C1-C4-alcoyle droit ou ramifié, amino, C1-C4-alkylamino, di-(C1-C4- alcoyle)-amino, carboxy, C1-C4-alkoxycarbonyle, un hydroxy, C1-C4-alkoxy, phénoxy, mercapto, C1-C4-alkylthio, phénylthio, halogène, trifulorométhyle; R2 représente l'hydrogène, C1-C8-alcoyle, halogène ou l'aryle-C1-C4-alcoyle; X représente 0 ou S, et n est un nombre entier entre 0 et 2; à condition que R2 ne soit pas de l'hydrogène ou du méthyle si n=O et si R1 est du méthyle. Les composés de l'invention sont d'une grande utilité en chimique humaine et vétérinaire.
• [EN] THE SYNTHESIS OF EXTENDED BIS(ETHYLENEDITHIO)TETRATHIAFULVALENE DERIVATIVES AND THEIR DIHYDROXYL ANALOGUES<br/>[FR] SYNTHESE DE DERIVES DE BIS(ETHYLENEDITHIO)TETRATHIAFULVALENE ALLONGES ET LEURS ANALOGUES DIHYDROXYLES
  申请人：TUBITAK MARMARA RES CT

  公开号：WO2001032645A1

  公开（公告）日：2001-05-10

  The present invention describes the synthesis of six novel derivatives of bis(ethylenedithio)tetrathiafulvalene (BEDT-TTF), utilising the recently developed reaction of 1,8-diketones with Lawesson's reagent. These new BEDT-TTF derivatives (1)-(6) have potential to delocalise the positive charges formed during change-transfer salts to the peripheral. In addition to their positive charge delocalisation feature, the compounds (1)-(3) have the potential of being introduced hydrogen bonding groups and the compound (4)-(6) already have hydrogen bonding hydroxyl groups. All the new BEDT-TTF (7) derivatives described in this invention have shown comparative CV measurements with the BEDT-TTF. Each of these bis(ethylenedithio)tetrathiafulvalene derivatives of the present invention has a unique and novel structure which can not be found in the prior art and is useful for the development of new organic charge-transfer complexes.
• Bisphosphonic acids and esters
  申请人：Leo Pharmaceutical Products, Ltd.

  公开号：US04732998A1

  公开（公告）日：1988-03-22

  The present invention relates to hitherto unknown compounds of the formula I ##STR1## in which R.sub.1 is a straight or branched, saturated or unsaturated aliphatic or alicyclic C.sub.1 -C.sub.10 hydrocarbon radical, an aryl or an aryl-C.sub.1 -C.sub.4 -alkyl radical, R.sub.1 if desired being unsubstituted or substituted with straight or branched C.sub.1 -C.sub.4 -alkyl, amino, C.sub.1 -C.sub.4 -alkamino, di-(C.sub.1 -C.sub.4 -alkyl)-amino, carboxy, C.sub.1 -C.sub.4 -alkoxycarbonyl, hydroxy, C.sub.1 -C.sub.4 -alkoxy, phenoxy, mercapto, C.sub.1 -C.sub.4 -alkylthio, phenylthio, halogen, trifluoromethyl; R.sub.2 stands for hydrogen, C.sub.1 -C.sub.8 -alkyl, aryl-C.sub.1 -C.sub.4 -alkyl or halogen; X is O or S, and n is an integer from 0 to 2; with the proviso that R.sub.2 cannot be hydrogen or methyl if n=O and R.sub.1 is methyl. The compounds of the invention are valuable in the human and veterinary practice.

  本发明涉及迄今为止未知的化合物，其化学式为I，在该式中，R.sub.1是直链或支链、饱和或不饱和的脂肪族或脂环族C.sub.1-C.sub.10烃基，芳基或芳基-C.sub.1-C.sub.4-烷基基团，R.sub.1如有必要，可以是未取代的或取代的，取代基为直链或支链C.sub.1-C.sub.4-烷基，氨基，C.sub.1-C.sub.4-烷氨基，二-(C.sub.1-C.sub.4-烷基)-氨基，羧基，C.sub.1-C.sub.4-烷氧羰基，羟基，C.sub.1-C.sub.4-烷氧基，苯氧基，巯基，C.sub.1-C.sub.4-烷硫基，苯硫基，卤素，三氟甲基；R.sub.2代表氢、C.sub.1-C.sub.8-烷基，芳基-C.sub.1-C.sub.4-烷基或卤素；X为氧或硫，n为0到2的整数；但R.sub.2不能为氢或甲基，如果n=0且R.sub.1为甲基。本发明的化合物在人类和兽医实践中具有重要价值。